Project cooperationUpdated on 6 January 2026
Enhancing Novel Vaccine Candidate Production Yields
External Scientific Program Manager at Virica Biotech
Ottawa, Canada
About
Virica is looking to join a consortium working towards the development and manufacturing of a novel vaccine candidate.
Virica's Viral Sensitizers (VSE™) are small-molecule media additives that temporarily dampen host-cell defenses, enhancing viral yields and quality across diverse manufacturing platforms. Beyond supplying VSEs as off-the-shelf reagents, Virica operates as a fast-turnaround service partner: our proprietary High-Throughput Virology (HTV™) platform, Design-of-Experiments (DoE) process optimization, and analytical testing workflows let developers rapidly pinpoint the best production conditions so programs can move to scale sooner and at lower cost.
We are looking to participate by contributing our small molecule enhancer technology, coupled with small scale process development expertise and high-throughput screening capabilities to optimize production of new vaccine candidates.
Topic
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
Type
- Partner seeks Consortium/Coordinator
Attached files
Organisation
Similar opportunities
Project cooperation
Protein design, modelling, optimisation
- Partner seeks Consortium/Coordinator
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
Abdullah Kahraman
Professor of Data Science in Life Sciences at School of Life Sciences, University of Applied Sciences Northwestern Switzerland
Muttenz, Switzerland
Project cooperation
Offering expertise in tailored antiviral strategies and viral models generation
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
Ilaria Carli
Principal Research Scientist at IRBM S.p.A.
Rome, Italy
Project cooperation
Novel "Innate" Approaches for Vaccines in Low- and Middle-Income Countries
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
Fabrizio Chiodo
Associate Professor (Italian National Research Council) at Consiglio Nazionale delle Ricerche
Palermo, Italy